Urendia Tablet 10 mg contains Finerenone, a selective non-steroidal mineralocorticoid receptor antagonist (MRA) used for the management of chronic kidney disease (CKD) in adults with type 2 diabetes. Finerenone helps reduce kidney damage and cardiovascular complications by blocking the effects of excess aldosterone, a hormone that can promote inflammation and fibrosis in the kidneys and heart.
Urendia is prescribed to slow the progression of CKD, protect kidney function, and lower the risk of cardiovascular events such as heart attack, stroke, or heart failure. It is particularly valuable for patients whose conditions require additional renal and cardiovascular protection beyond standard treatments like ACE inhibitors or ARBs.
Finerenone offers a targeted approach to mineralocorticoid receptor modulation, providing effective kidney and heart protection with a lower risk of side effects commonly associated with steroidal MRAs, such as hyperkalemia or hormonal imbalances.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Each tablet contains:
Finerenone – 10 mg
Urendia Tablet 10 mg is indicated for:
Management of chronic kidney disease (CKD) in adults with type 2 diabetes
Reduction of the risk of kidney function decline in CKD patients
Prevention of cardiovascular events in patients with CKD and type 2 diabetes
Use as part of a comprehensive treatment plan including diet, lifestyle, and other medications
Finerenone selectively blocks mineralocorticoid receptors, preventing aldosterone from binding and activating these receptors in the kidneys, heart, and blood vessels. This results in:
Reduced inflammation and fibrosis in kidney tissue
Improved kidney function and slower progression of CKD
Decreased cardiovascular stress and reduced risk of heart-related complications
Unlike steroidal MRAs, Finerenone provides targeted protection with a lower likelihood of causing electrolyte disturbances.
Urendia Tablet should be taken exactly as prescribed by a healthcare professional:
Tablets are taken orally, usually once daily, with or without food.
The dose may be adjusted based on kidney function and potassium levels.
Regular monitoring of serum potassium, kidney function, and blood pressure is required during therapy.
Patients should not adjust the dose or discontinue treatment without medical guidance.
Use with caution in patients with hyperkalemia or severe kidney impairment.
Not recommended during pregnancy or breastfeeding unless specifically prescribed.
Inform your doctor about all other medications, especially potassium-sparing diuretics or supplements.
Avoid sudden discontinuation of therapy to maintain kidney and cardiovascular protection.
Finerenone is generally well tolerated, but some patients may experience:
Elevated potassium levels (hyperkalemia)
Dizziness or fatigue
Headache
Mild gastrointestinal discomfort
Severe hyperkalemia or kidney function deterioration requires immediate medical attention.
Store below 30°C in a dry, cool place.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet